WallStreetZenWallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for TAK

Based on 1 analyst offering 12 month price targets for Takeda Pharmaceutical Co Ltd.
Min Forecast
$24.00+61.73%
Avg Forecast
$24.00+61.73%
Max Forecast
$24.00+61.73%

Should I buy or sell TAK stock?

Based on 1 analyst offering ratings for Takeda Pharmaceutical Co Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TAK stock forecasts and price targets.

TAK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cowen & Co.
Bottom 9%
9
BuyUpgrades$24.00+61.73%2022-07-19

1 of 1

Forecast return on equity

Is TAK forecast to generate an efficient return?
Company
N/A
Industry
26.2%
Market
62.68%

Forecast return on assets

Is TAK forecast to generate an efficient return on assets?
Company
N/A
Industry
13.45%

TAK earnings per share forecast

What is TAK's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$2.25+216.46%
Avg 2 year Forecast
$0.70-1.55%

TAK revenue forecast

What is TAK's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$28.8B-11.92%
Avg 2 year Forecast
$26.2B-19.93%
Avg 3 year Forecast
$26.8B-17.95%
TAK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TAK revenue growth forecast

How is TAK forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
-6.66%
Industry
3.57%
Market
6.67%
TAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TAK vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TAK$14.84$24.00+61.73%Buy
ZTS$153.68$219.17+42.61%Strong Buy
VTRS$10.96$12.88+17.47%Hold
TEVA$8.32$10.38+24.70%Hold
RDY$53.71$67.00+24.74%Strong Buy

Takeda Pharmaceutical Co Stock Forecast FAQ

Is Takeda Pharmaceutical Co Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: TAK) stock is to Buy TAK stock.

Out of 1 analyst, 0 (0%) are recommending TAK as a Strong Buy, 1 (100%) are recommending TAK as a Buy, 0 (0%) are recommending TAK as a Hold, 0 (0%) are recommending TAK as a Sell, and 0 (0%) are recommending TAK as a Strong Sell.

If you're new to stock investing, here's how to buy Takeda Pharmaceutical Co stock.

What is TAK's earnings growth forecast for 2023-2024?

(NYSE: TAK) Takeda Pharmaceutical Co's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 14.9%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.05%.

Takeda Pharmaceutical Co's earnings in 2022 is $2,175,868,673.On average, 1 Wall Street analyst forecast TAK's earnings for 2023 to be $3,748,721,483, with the lowest TAK earnings forecast at $3,748,721,483, and the highest TAK earnings forecast at $3,748,721,483.

In 2024, TAK is forecast to generate $1,166,268,906 in earnings, with the lowest earnings forecast at $1,166,268,906 and the highest earnings forecast at $1,166,268,906.

What is TAK's revenue growth forecast for 2023-2025?

(NYSE: TAK) Takeda Pharmaceutical Co's forecast annual revenue growth rate of -6.66% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.67%.

Takeda Pharmaceutical Co's revenue in 2022 is $32,296,983,584.On average, 1 Wall Street analysts forecast TAK's revenue for 2023 to be $47,954,594,889,843, with the lowest TAK revenue forecast at $47,954,594,889,843, and the highest TAK revenue forecast at $47,954,594,889,843. On average, 1 Wall Street analysts forecast TAK's revenue for 2024 to be $43,592,299,335,199, with the lowest TAK revenue forecast at $43,592,299,335,199, and the highest TAK revenue forecast at $43,592,299,335,199.

In 2025, TAK is forecast to generate $44,669,631,906,532 in revenue, with the lowest revenue forecast at $44,669,631,906,532 and the highest revenue forecast at $44,669,631,906,532.

What is TAK's forecast return on assets (ROA) for 2023-2025?

(NYSE: TAK) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.45%.

What is TAK's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TAK price target, the average TAK price target is $24.00, with the highest TAK stock price forecast at $24.00 and the lowest TAK stock price forecast at $24.00.

The Wall Street analyst predicted that Takeda Pharmaceutical Co's share price could reach $24.00 by Jul 19, 2023. The average Takeda Pharmaceutical Co stock price prediction forecasts a potential upside of 61.73% from the current TAK share price of $14.84.

What is TAK's Earnings Per Share (EPS) forecast for 2023-2024?

(NYSE: TAK) Takeda Pharmaceutical Co's current Earnings Per Share (EPS) is $0.70. On average, analysts forecast that TAK's EPS will be $2.25 for 2023, with the lowest EPS forecast at $2.25, and the highest EPS forecast at $2.25. In 2024, TAK's EPS is forecast to hit $0.70 (min: $0.70, max: $0.70).

What is TAK's forecast return on equity (ROE) for 2023-2025?

(NYSE: TAK) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.